Searching journal content for biomarker discovery (as phrase) in full text.

Displaying results 1-10 of 21

For checked items

view abstracts
download to citation manager

Select this article
Research:
- Siker Kimbung,
- Ching-yi Chang,
- Pär-Ola Bendahl,
- Laura Dubois,
- J Will Thompson,
- Donald P McDonnell,
- and Signe Borgquist
Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer Endocr Relat Cancer 24 (7) 339-349, doi:10.1530/ERC-16-0533 first published on 25 April 2017
...biomarker discovery trials (Higgins et al. 2012), including the results from the window-of-opportunity trial (Bjarnadottir et al. 2013) presented herein, have unanimously confirmed that the compliance to statin treatment is remarkably high and that these drugs effectively decrease serum total ch ~~~
OPEN ACCESS ARTICLE
Select this article
Thematic Review:
- John W Cassidy,
- Ankita S Batra,
- Wendy Greenwood,
- and Alejandra Bruna
Patient-derived tumour xenografts for breast cancer drug discovery Endocr Relat Cancer 23 (12) T259-T270, doi:10.1530/ERC-16-0251 first published on 4 October 2016
...biomarker discovery f high-throughput screening f patient-derived tumour xenografts f targeted therapies f pharmacogenomics Introduction Breast cancer (herein BC) is not a single disease, but is instead a collection of diseases that have distinct histopathological features and genetic and genomic va ~~~
OPEN ACCESS ARTICLE
Select this article
Review:
- Ju-Yeon Moon,
- Man Ho Choi,
- and Jayoung Kim
Metabolic profiling of cholesterol and sex steroid hormones to monitor urological diseases Endocr Relat Cancer 23 (10) R455-R467, doi:10.1530/ERC-16-0285
...biomarker discovery . Theranostics 4 953 – 959 . ( doi:10.7150/thno.9265 ) ↵ Thomson S , Koren G , Van Steen V , Rieder M & Van Uum SH 2009 Testosterone concentrations in hair of hypogonadal men with and without testosterone replacement therapy . Therapeutic Drug Monitoring 31 779 – 782 . ( doi: ~~~
OPEN ACCESS ARTICLE
Select this article
Research:
- Duane H Hamilton,
- Mario Roselli,
- Patrizia Ferroni,
- Leopoldo Costarelli,
- Francesco Cavaliere,
- Mariateresa Taffuri,
- Claudia Palena,
- and Fiorella Guadagni
Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer Endocr Relat Cancer 23 (10) 783-796, doi:10.1530/ERC-16-0037
...biomarker discovery ~~~
Select this article
Review:
- Laura A Baker,
- Holly Holliday,
- and Alexander Swarbrick
ID4 controls luminal lineage commitment in normal mammary epithelium and inhibits BRCA1 function in basal-like breast cancer Endocr Relat Cancer 23 (9) R381-R392, doi:10.1530/ERC-16-0196 first published on 13 July 2016
...biomarker discovery is crucial to improving treatment options and patient survival, as is the discovery of new therapeutic vulnerabilities in BLBC. Basal cytokeratins are highly expressed in BLBC ((Prat et al. 2013) and reviewed in Gusterson et al. 2005). Accordingly, initial research suggested that ~~~
Select this article
Review:
- Lisa M Butler,
- Margaret M Centenera,
- and Johannes V Swinnen
Androgen control of lipid metabolism in prostate cancer: novel insights and future applications Endocr Relat Cancer 23 (5) R219-R227, doi:10.1530/ERC-15-0556 first published on 29 April 2016
...biomarker discovery and applications, including smart knife technologies. Moreover, as changes in lipid profiles can be measured in body fluids, and potentially visualized in tumors by molecular imaging, there is a high potential for the development of specific and minimally invasive tests. Most rec ~~~
Select this article
Research:
- Pauline Croisé,
- Sébastien Houy,
- Mathieu Gand,
- Joël Lanoix,
- Valérie Calco,
- Petra Tóth,
- Laurent Brunaud,
- Sandra Lomazzi,
- Eustache Paramithiotis,
- Daniel Chelsky,
- Stéphane Ory,
- and Stéphane Gasman
Cdc42 and Rac1 activity is reduced in human pheochromocytoma and correlates with FARP1 and ARHGEF1 expression Endocr Relat Cancer 23 (4) 281-293, doi:10.1530/ERC-15-0502 first published on 24 February 2016
...biomarker discovery by mass spectrometry. Journal of Proteome Research 8 3797–3807. (doi:10.1021/pr800389e) Song JY, Lee JK, Lee NW, Jung HH, Kim SH & Lee KW 2008 Microarray analysis of normal cervix, carcinoma in situ, and invasive cervical cancer: Identification of candidate genes in pathogenesis ~~~
Select this article
Review:
- Kristina Warton,
- Kate L Mahon,
- and Goli Samimi
Methylated circulating tumor DNA in blood: power in cancer prognosis and response Endocr Relat Cancer 23 (3) R157-R171, doi:10.1530/ERC-15-0369 first published on 13 January 2016
...biomarker discovery and development pathway has attempted to standardize biomarker development and provide an efficient framework tomove useful biomarkers into clinical practice. All large Phase III therapeutic studies should collect prospective samples that are rationally devised to test available ~~~
OPEN ACCESS ARTICLE
Select this article
Research:
- Debora Degl'Innocenti,
- Paola Romeo,
- Eva Tarantino,
- Marialuisa Sensi,
- Giuliana Cassinelli,
- Veronica Catalano,
- Cinzia Lanzi,
- Federica Perrone,
- Silvana Pilotti,
- Ettore Seregni,
- Marco A Pierotti,
- Angela Greco,
- and Maria Grazia Borrello
DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells Endocr Relat Cancer 20 (1) 23-37, doi:10.1530/ERC-12-0078 first published on 6 November 2012
...biomarker discovery for colorectal cancers. Recent Patents on DNA & Gene Sequences 4 86–93. (doi:10.2174/187221510793205764) Roccato E, Miranda C, Ranzi V, Gishizky ML, Pierotti MA & Greco A 2002 Biological activity of the thyroid TRK-T3 oncogene requires signalinghttp://www..endocrinology-journals. ~~~
Select this article
Review:
- Luke A Selth,
- Wayne D Tilley,
- and Lisa M Butler
Circulating microRNAs: macro-utility as markers of prostate cancer? Endocr Relat Cancer 19 (4) R99-R113, doi:10.1530/ERC-12-0010 first published on 5 April 2012
...biomarker discovery studies (Cortez et al. 2011). Thirdly, there is evidence for selective secretion of miRNAs in exosomes. For example, the bulk of miR-1246 and miR-451 was found to be released by breast cancer MCF7 cells in exosomes, but these miRNAs were retained by a nonmalignant mammary epithel ~~~

For checked items

view abstracts
download to citation manager

Endocrine-Related Cancer

Searching journal content for biomarker discovery (as phrase) in full text.

Search Results

Modify Results

This search

New Articles: issue in progress

Most

Viewed

Cited

Citation format:
Results / page:
Results order: